Navigation Links
High risk of acute mountain sickness on Mount Kilimanjaro
Date:10/6/2010

New Rochelle, NY, October 6, 2010 Climbers of high peaks such as Mount Kilimanjaro are at high risk for Acute Mountain Sickness (AMS). Trekkers should not ignore AMS warning signs, which can progress to more serious medical outcomes. Mountain climbers can best minimize their risk for altitude sickness by becoming acclimatized to increased altitudes before an ascent, according to a study in the current issue of High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article is available free online at www.liebertpub.com/ham

The study, entitled "Incidence and predictors of acute mountain sickness among trekkers on Mount Kilimanjaro," evaluated the incidence of AMS among trekkers of this popular climbing destination. Stewart Jackson, J. Kenneth Baillie, and colleagues from University of Edinburgh (Scotland) and Muhimbili University College of Health Science (Tanzania), compared the effects of three increasingly difficult and rapid ascent routes, the option of a single rest day during the climb, and use by a sub-group of climbers of prophylactic acetazolamide.

The authors reported a similar rate of AMS among climbers with or without prophylactic drug use. Furthermore, a mid-climb rest day did not affect the incidence of AMS. Only prior acclimatization to increased altitude offered a significant protective effect against AMS.

"This important article emphasizes the dangers of rapid ascent rates on a mountain that attracts thousands of visitors every year. Hopefully it will help to reduce the high frequency of high altitude diseases," says John B. West, MD, PhD, Editor-in-Chief of High Altitude Medicine & Biology and Professor of Medicine at the University of California, San Diego School of Medicine.


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2156
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert  

Page: 1

Related biology news :

1. Vitamin C rapidly improves emotional state of acutely hospitalized patients, say LDI researchers
2. CoLucid Pharmaceuticals, Inc. announces study data documenting oral efficacy of lasmiditan (COL-144), a selective 5-HT1F receptor agonist, in the treatment of acute migraine attacks
3. Drinking alcohol during pregnancy could lead to acute myeloid leukemia in children
4. Vicious circle offers new acute leukemia treatment target
5. Study shows pine bark naturally relieves symptoms of acute hemorrhoids
6. First-in-class treatment for acute leukemia
7. Inherited risk factors increase odds of developing childhood acute lymphoblastic leukemia
8. Pitt team first to profile genes in acutely ill idiopathic pulmonary fibrosis patients
9. A miR boost enables acute leukemia cells to mature
10. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
11. When acute hepatitis develops into chronic hepatitis
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
High risk of acute mountain sickness on Mount Kilimanjaro
(Date:4/5/2017)... 5, 2017 Today HYPR Corp. , ... server component of the HYPR platform is officially ... end-to-end security architecture that empowers biometric authentication across Fortune ... already secured over 15 million users across the financial ... connected home product suites and physical access represent a ...
(Date:3/30/2017)... LOS ANGELES , March 30, 2017  On ... Hack the Genome hackathon at ... This exciting two-day competition will focus on developing health ... experience. Hack the Genome is ... has been tremendous. The world,s largest companies in the ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):
(Date:6/14/2017)... 14, 2017   Micralyne Inc., a ... primary supplier of sensors, is pleased to announce ... California to develop and manufacture custom ... joint development of this technology leverages the specific ... flexible and cost effective Metal TSV solution for ...
(Date:6/14/2017)... ... June 13, 2017 , ... ... understanding the phenotype of an organism on a molecular level that is ... data processing remain major bottlenecks to biomarker discovery in clinical-based metabolomics research. ...
(Date:6/13/2017)... , ... June 13, 2017 , ... ... City Science Center’s Phase 1 Ventures (P1V) program. PolyCeramX, Recensa Therapeutics and Regennera, ... and commercialization activities. , Phase 1 Ventures is a startup accelerator that ...
(Date:6/13/2017)... London UK (PRWEB) , ... June 13, 2017 , ... ... and Study on Clinical Trial Participation (CISCRP) and the Society for Clinical Research Sites ... will provide background on the purpose of eConsent and the ability for eConsent to ...
Breaking Biology Technology: